-0.0400   (-1.24%)
After Hours: 3.17 -0.0100 (-0.31%)
Volume (24h) Market Cap. Day Range 52w Range
5.94M 2.13B 3.13 - 3.24 1.12 - 6.47
Sep-28-20 09:45PM OPKO Health (OPK) Stock Sinks As Market Gains: What You Should KnowZacks
Sep-25-20 03:30PM Has OPKO Health (OPK) Outpaced Other Medical Stocks This Year?Zacks
Sep-22-20 09:45PM OPKO Health (OPK) Stock Sinks As Market Gains: What You Should KnowZacks
Sep-16-20 01:25PM OPKO Health Initiates Mid-Stage Study on Coronavirus TherapyZacks
08:48AM Opko Launches Phase 2 Trial Of Covid Treatment Rayaldee; Street BullishSmarterAnalyst
Sep-15-20 09:45PM OPKO Health (OPK) Stock Sinks As Market Gains: What You Should KnowZacks
01:05PM Opko Shares Climb on Phase 2 Trial of Coronavirus TreatmentTheStreet.com
Sep-15-20 11:29AM Shares of Okpo Health jump on plans to test vitamin D drug in COVID-19 patientsMarketWatch
11:00AM OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 PatientsGlobeNewswire
Sep-09-20 03:30PM Is OPKO Health (OPK) Outperforming Other Medical Stocks This Year?Zacks
Sep-08-20 07:58PM Why These 3 Coronavirus-Related Stocks Plummeted More Than 35% in AugustMotley Fool
05:19PM Does OPKO Health's (NASDAQ:OPK) CEO Salary Compare Well With Industry Peers?Simply Wall St.
Sep-03-20 01:17PM OPKO Health's BioReference Laboratories Introduces NGS AssayZacks
Sep-02-20 08:05PM OPKO Health to Participate in Two September Investment ConferencesGlobeNewswire
07:18PM Why Opko Health's Stock Is Trading Higher TodayBenzinga
Sep-02-20 12:17PM 2 Great Stocks Under $10Motley Fool
12:00PM OPKO Health's BioReference Laboratories Announces New York City Schools COVID-19 Testing ProgramPR Newswire
Sep-01-20 07:55PM OPKO Health's BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) AssayPR Newswire
Aug-29-20 03:32PM Why Is OPKO Health (OPK) Down 43.5% Since Last Earnings Report?Zacks
Aug-27-20 04:39PM Why Co-Diagnostics, GenMark, Luminex, and Opko Stocks Are Sinking TodayMotley Fool
Aug-25-20 01:13PM Shares of Opko Health Are Still 'Testing Negative'TheStreet.com
Aug-24-20 04:40PM The Zacks Analyst Blog Highlights: QIAGEN, Merit Medical, OPKO, Abbott and AbiomedZacks
03:30PM Is OPKO Health (OPK) Outperforming Other Medical Stocks This Year?Zacks
Aug-24-20 02:26PM Opko Investigating False Positive Covid-19 Tests From NFL TeamsBloomberg
Aug-17-20 12:54PM Do Options Traders Know Something About OPKO Health (OPK) Stock We Don't?Zacks
Aug-14-20 03:12PM The Charts of Opko Health Suggest it Can Correct Further to the DownsideTheStreet.com
Aug-13-20 12:06PM HMS Holdings (HMSY) Loses 2.9% Since Q2 Earnings ReleaseZacks
Aug-12-20 04:04PM ROCE Insights For OPKO HealthBenzinga
01:15PM OPKO Health's GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic ServicesPR Newswire
Aug-10-20 12:17PM Surmodics (SRDX) Q3 Earnings and Revenues Beat EstimatesZacks
Aug-07-20 03:30PM Has OPKO Health (OPK) Outpaced Other Medical Stocks This Year?Zacks
11:20AM Nevro (NVRO) Q2 Loss Narrower than Expected, Revenues BeatZacks
Aug-06-20 12:00PM OPKO Health's GeneDx Adds GenomeXpress to Its Industry-Leading Clinical Genomics PortfolioPR Newswire
Aug-05-20 07:35PM OPKO Health to Participate in BTIG Virtual Biotechnology ConferenceGlobeNewswire
Aug-03-20 05:40PM Unusual Options Activity Insight: OPKO HealthBenzinga
04:00PM OPKO Health (OPK) is a Great Momentum Stock: Should You Buy?Zacks
Jul-31-20 10:57PM Why Shares of Coronavirus Stock Opko Health Plunged by 13% on FridayMotley Fool
04:14PM DaVita (DVA) Earnings Beat Estimates in Q2, Revenues MissZacks
Jul-31-20 03:43PM NextGen Healthcare (NXGN) Tops Q1 Earnings & Revenue EstimatesZacks
02:16PM OPKO Health Grows Revenue by 33% on the Back of Its COVID-19 TestsMotley Fool
Jul-31-20 12:32PM OPKO Health (OPK) Q2 Earnings and Revenues Beat EstimatesZacks
Jul-30-20 11:10PM OPKO Health (OPK) Q2 Earnings and Revenues Surpass EstimatesZacks
08:05PM OPKO Health Reports 2020 Second Quarter Business Highlights and Financial ResultsGlobeNewswire
Jul-29-20 01:33PM OPKO Health (OPK) to Report Q2 Earnings: What's in Store?Zacks
11:15AM 3 Great Stocks Under $10Motley Fool
Jul-28-20 12:40PM Got $2,000 in Cash? Put It Into This Company Testing for Coronavirus in Pro SportsMotley Fool
Jul-27-20 03:23PM Why Opko Health's Stock Is Trading Higher TodayBenzinga
12:00PM OPKO Health to Report Second Quarter 2020 Financial Results on July 30, 2020GlobeNewswire
Jul-23-20 09:50PM OPKO Health (OPK) Gains As Market Dips: What You Should KnowZacks
Jul-22-20 07:13PM Morning Bell With Jim Cramer: Tesla Reports EarningsTheStreet.com
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates Bio-Reference Laboratories, a clinical laboratory that offers laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. The company's pharmaceutical segment offers Rayaldee, a treatment for secondary hyperparathyroidism in adults with stage 3-4 chronic kidney disease patients with vitamin D deficiency; and VARUBI for chemotherapy-induced nausea and vomiting. This segment is also developing OPK88004, an androgen receptor modulator for benign prostate hypertrophy and other urologic and metabolic conditions; OPK88003, a once or twice weekly oxyntomodulin for type 2 diabetes and obesity; hGH-CTP, a growth hormone injection that is in Phase III clinical trials; and Factor VIIa drug for hemophilia. In addition, it develops and produces specialty active pharmaceutical ingredients; and discovers drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, this segment engages in the development, manufacture, marketing, and sale of pharmaceutical, nutraceutical, and veterinary products; and markets and distributes pharmaceutical and natural products. Additionally, OPKO Health, Inc. operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was incorporated in 1991 and is headquartered in Miami, Florida.
Cap:    |  Volume (24h):